Biotech

All Articles

Novo inks $600M NanoVation offer to examine genetic drugs ex-liver

.Novo Nordisk is actually proceeding its press right into hereditary medicines, consenting to pay Na...

Innovent links cytokine to colon cancer cells reactions

.Innovent Biologics has helped make the instance that its checkpoint inhibitor-cytokine combination ...

Merck, Daiichi ADC reaches goal in stage 3 bronchi cancer research

.A period 3 test of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) ...

Rakovina deepens artificial intelligence center with collab to decide on cancer aim ats

.5 months after Rakovina Therapeutics turned towards expert system, the cancer-focused biotech has s...

Ascendis' dwarfism drug favorites in stage 3, endangers BioMarin

.Ascendis Pharma has emerged as a prospective hazard to BioMarin's Voxzogo, reporting stage 3 growth...

Despite ph. 3 miss, Alkeus finds pathway in advance for eye condition property

.Though Alkeus Pharmaceuticals' oral eye condition possession failed to considerably reduce geograph...

Kairos goes public with $6M IPO to finance tests of cancer cells medication

.With a triad of biotechs striking the Nasdaq on Friday, it was actually very easy to miss a smaller...

Vaccine and Keytruda combo helpful in squamous tissue cancer

.Invulnerable gate preventions are actually the superheroes of cancer cells treatment. Medicines lik...

Cue Biopharma mark time J&ampJ vet as CBO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of considerable management hirings, firings and ...

Regeneron's Opdualag competitor reveals 57% feedback cost

.Regeneron is back along with long-term follow-up for its LAG-3 inhibitor and PD-1 inhibitor combina...